Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kapil Gadkar

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
Clinical and Translational Science|March 13, 2023
Systems-based digital twins to help characterize clinical dose-response and propose predictive biomarkers in a Phase I study of bispecific antibody, mosunetuzumab, in NHLMonica E Susilo, Chi-Chung Li, Kapil Gadkar, et al.
CPT: Pharmacometrics & Systems Pharmacology|July 20, 2022
Integrated systems modeling of severe asthma: Exploration of IL-33/ST2 antagonismKapil Gadkar, Justin Feigelman, Siddharth Sukumaran, et al.
Pharmaceutics|May 25, 2024
A Minimal PBPK/PD Model with Expansion-Enhanced Target-Mediated Drug Disposition to Support a First-in-Human Clinical Study Design for a FLT3L-Fc MoleculeIraj Hosseini, Brett Fleisher, Jennifer Getz, et al.
Clinical Pharmacology and Therapeutics|December 31, 2025
Bridging the Gap: Integrating Quantitative Systems Pharmacology and Pharmacometrics in Drug DevelopmentGeorgi I Kapitanov, Justin C Earp, Kapil Gadkar, et al.
The AAPS Journal|September 29, 2016
Development and Translational Application of an Integrated, Mechanistic Model of Antibody-Drug Conjugate PharmacokineticsSiddharth Sukumaran, Crystal Zhang, Douglas D Leipold, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|January 29, 2016
Mathematical PKPD and safety model of bispecific TfR/BACE1 antibodies for the optimization of antibody uptake in brainKapil Gadkar, Daniela Bumbaca Yadav, Joy Yu Zuchero, et al.
Pharmaceutical Research|December 3, 2014
Mechanism-Based Pharmacokinetic/Pharmacodynamic Model for THIOMAB™ Drug ConjugatesSiddharth Sukumaran, Kapil Gadkar, Crystal Zhang, et al.
Investigative Ophthalmology & Visual Science|August 15, 2015
Design and Pharmacokinetic Characterization of Novel Antibody Formats for Ocular TherapeuticsKapil Gadkar, Cinthia V Pastuskovas, Jennifer E Le Couter, et al.
Science Translational Medicine|October 19, 2018
Avidity-based binding to HER2 results in selective killing of HER2-overexpressing cells by anti-HER2/CD3Dionysos Slaga, Diego Ellerman, T Noelle Lombana, et al.
Clinical Pharmacology and Therapeutics|September 19, 2024
Industry Perspective on First-in-Human and Clinical Pharmacology Strategies to Support Clinical Development of T-Cell Engaging Bispecific Antibodies for Cancer TherapyPrathap Nagaraja Shastri, Nirav Shah, Martin Lechmann, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Clinical and Translational Science|March 13, 2023
Systems-based digital twins to help characterize clinical dose-response and propose predictive biomarkers in a Phase I study of bispecific antibody, mosunetuzumab, in NHLMonica E Susilo, Chi-Chung Li, Kapil Gadkar, et al.
CPT: Pharmacometrics & Systems Pharmacology|July 20, 2022
Integrated systems modeling of severe asthma: Exploration of IL-33/ST2 antagonismKapil Gadkar, Justin Feigelman, Siddharth Sukumaran, et al.
Pharmaceutics|May 25, 2024
A Minimal PBPK/PD Model with Expansion-Enhanced Target-Mediated Drug Disposition to Support a First-in-Human Clinical Study Design for a FLT3L-Fc MoleculeIraj Hosseini, Brett Fleisher, Jennifer Getz, et al.
Clinical Pharmacology and Therapeutics|December 31, 2025
Bridging the Gap: Integrating Quantitative Systems Pharmacology and Pharmacometrics in Drug DevelopmentGeorgi I Kapitanov, Justin C Earp, Kapil Gadkar, et al.
The AAPS Journal|September 29, 2016
Development and Translational Application of an Integrated, Mechanistic Model of Antibody-Drug Conjugate PharmacokineticsSiddharth Sukumaran, Crystal Zhang, Douglas D Leipold, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|January 29, 2016
Mathematical PKPD and safety model of bispecific TfR/BACE1 antibodies for the optimization of antibody uptake in brainKapil Gadkar, Daniela Bumbaca Yadav, Joy Yu Zuchero, et al.
Pharmaceutical Research|December 3, 2014
Mechanism-Based Pharmacokinetic/Pharmacodynamic Model for THIOMAB™ Drug ConjugatesSiddharth Sukumaran, Kapil Gadkar, Crystal Zhang, et al.
Investigative Ophthalmology & Visual Science|August 15, 2015
Design and Pharmacokinetic Characterization of Novel Antibody Formats for Ocular TherapeuticsKapil Gadkar, Cinthia V Pastuskovas, Jennifer E Le Couter, et al.
Science Translational Medicine|October 19, 2018
Avidity-based binding to HER2 results in selective killing of HER2-overexpressing cells by anti-HER2/CD3Dionysos Slaga, Diego Ellerman, T Noelle Lombana, et al.
Clinical Pharmacology and Therapeutics|September 19, 2024
Industry Perspective on First-in-Human and Clinical Pharmacology Strategies to Support Clinical Development of T-Cell Engaging Bispecific Antibodies for Cancer TherapyPrathap Nagaraja Shastri, Nirav Shah, Martin Lechmann, et al.
Pageof 3